{"id":"https://openalex.org/W4221043471","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01","title":"Abstract P3-08-01: Clonal hematopoiesis of indeterminate potential (CHIP) in metastatic triple negative breast cancer","display_name":"Abstract P3-08-01: Clonal hematopoiesis of indeterminate potential (CHIP) in metastatic triple negative breast cancer","publication_year":2022,"publication_date":"2022-02-15","ids":{"openalex":"https://openalex.org/W4221043471","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs21-p3-08-01","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102799583","display_name":"Katheryn Santos","orcid":"https://orcid.org/0000-0002-3945-7644","observed_orcids":["https://orcid.org/0000-0002-3945-7644"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katheryn Santos","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008682981","display_name":"Qingchun Jin","orcid":"https://orcid.org/0000-0001-6388-5123","observed_orcids":["https://orcid.org/0000-0001-6388-5123"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qingchun Jin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090425082","display_name":"Peter Grant Miller","orcid":"https://orcid.org/0000-0002-6797-9335","observed_orcids":["https://orcid.org/0000-0002-6797-9335"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter G. Miller","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064407331","display_name":"Ashka Patel","orcid":"https://orcid.org/0009-0004-6128-5510","observed_orcids":["https://orcid.org/0009-0004-6128-5510"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashka Patel","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011491566","display_name":"Gregory John Kirkner","orcid":"https://orcid.org/0009-0005-0386-5223","observed_orcids":["https://orcid.org/0009-0005-0386-5223"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J. Kirkner","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024266349","display_name":"Janet L. Files","orcid":"https://orcid.org/0009-0009-7708-9991","observed_orcids":["https://orcid.org/0009-0009-7708-9991"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet L. Files","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015055171","display_name":"Melissa E. Hughes","orcid":"https://orcid.org/0000-0001-6190-9101","observed_orcids":["https://orcid.org/0000-0001-6190-9101"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa E. Hughes","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Samantha M. Stokes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha M. Stokes","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062515397","display_name":"Nabihah Tayob","orcid":"https://orcid.org/0000-0001-6088-167X","observed_orcids":["https://orcid.org/0000-0001-6088-167X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nabihah Tayob","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049785882","display_name":"Daniel G. Stover","orcid":"https://orcid.org/0000-0001-9003-8165","observed_orcids":["https://orcid.org/0000-0001-9003-8165"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel G. Stover","raw_affiliation_strings":["Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050468541","display_name":"Christopher James Gibson","orcid":"https://orcid.org/0000-0002-3700-5310","observed_orcids":["https://orcid.org/0000-0002-3700-5310"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Gibson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy E. Garber","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088801158","display_name":"Heather Anne Parsons","orcid":"https://orcid.org/0000-0001-8178-6612","observed_orcids":["https://orcid.org/0000-0001-8178-6612"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather A. Parsons","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"4_Supplement","first_page":"P3","last_page":"08"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.996999979019165},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.9020000100135803},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ppm1d","display_name":"PPM1D","score":0.8820000290870667},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":0.9610000252723694},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.5},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6830000281333923},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hematologic-malignancy-risk","display_name":"hematologic malignancy risk","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6939556002616882},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6880244016647339},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6153474450111389},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6062471270561218},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5924975872039795},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.501662015914917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4823295772075653},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3599468469619751}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs21-p3-08-01","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p3-08-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390660487","https://openalex.org/W4388048049","https://openalex.org/W4367311704","https://openalex.org/W4414342063","https://openalex.org/W2988153999","https://openalex.org/W4379282016","https://openalex.org/W4399328009","https://openalex.org/W4322769903","https://openalex.org/W4389243985","https://openalex.org/W4389230290"],"abstract_inverted_index":{"Abstract":[0],"Background.":[1],"Patients":[2],"(pts)":[3],"with":[4,17,49,88,97,231,245,261,282,313,320,338,371,399,439,458],"metastatic":[5,108,182,419,453,511],"triple":[6,512],"negative":[7,513],"breast":[8,64,514],"cancer":[9,65,515],"(mTNBC)":[10],"receive":[11],"serial":[12,422],"cytotoxic":[13],"chemotherapy":[14,293,308],"regimens,":[15],"often":[16],"cumulative":[18],"myelosuppressive":[19],"effects,":[20],"impairing":[21],"treatment":[22,75,427],"tolerance.":[23],"Clonal":[24,504],"hematopoiesis":[25,505],"of":[26,34,47,61,107,114,129,142,165,181,185,221,274,307,325,364,366,377,397,408,432,437,445,452,506,519],"indeterminate":[27,507],"potential":[28,508],"(CHIP)":[29,509],"refers":[30],"to":[31,69,297,334,343,390],"the":[32,45,58,127,146,208,406,418,448,520],"detection":[33],"somatic":[35,134],"mutations":[36],"in":[37,41,44,72,207,305,382,395,417,426,447,510],"genes":[38,187],"recurrently":[39],"mutated":[40,186],"hematologic":[42,52],"malignancies":[43],"blood":[46,101,117,222,298,335,423],"adults":[48],"no":[50,302],"evident":[51],"abnormalities.":[53],"Little":[54],"is":[55],"known":[56,270],"about":[57],"natural":[59],"history":[60],"CHIP":[62,71,125,149,172,232,246,252,262,268,283,289,321,328,339,346,378,388,409,446],"after":[63],"treatment.":[66],"We":[67,110,144,168],"sought":[68],"characterize":[70],"pts":[73,87,176,230,239,244,250,260,266,281,287,319,326,356,398],"undergoing":[74],"for":[76,229,238,294,405],"mTNBC.":[77],"Methods.":[78],"In":[79],"this":[80,435],"retrospective":[81],"cohort":[82,209,436],"study":[83,403],"we":[84],"identified":[85,169],"149":[86],"biopsy-proven":[89],"mTNBC":[90,295,372,441],"at":[91,98,130,137,219,410],"a":[92,374,412],"single":[93,413],"tertiary":[94],"care":[95],"institution":[96],"least":[99,131],"one":[100,132],"sample":[102],"collected":[103],"within":[104,178],"six":[105,179,450],"months":[106,180,212,451],"diagnosis.":[109,183],"performed":[111],"targeted":[112],"sequencing":[113],"cryopreserved":[115],"peripheral":[116],"mononuclear":[118],"cell":[119],"(PBMC)-derived":[120],"genomic":[121],"DNA":[122],"and":[123,151,161,163,247,263,284],"defined":[124],"as":[126,189],"presence":[128,407,444],"pathogenic":[133],"mutation":[135,159,272],"present":[136],"variant":[138],"allelic":[139],"fraction":[140],"(VAF)":[141],"0.02-0.35.":[143],"assessed":[145,404],"relationship":[147],"between":[148,311],"status":[150],"overall":[152],"survival":[153],"(OS),":[154],"demographics,":[155],"clinicopathologic":[156],"features,":[157],"germline":[158,271],"status,":[160],"type":[162,306],"timing":[164],"therapy.":[166],"Results.":[167],"27":[170],"unique":[171],"variants":[173],"across":[174],"22/149":[175],"(15%)":[177],"Frequency":[184],"were":[188,253,269,301],"follows:":[190],"DNMT3A":[191],"(n=15),":[192],"PPM1D":[193],"(n=4),":[194],"TP53":[195],"(n=3),":[196],"TET2":[197],"(n=2),":[198],"SRCAP":[199],"(n=1),":[200,202],"ZBTB33":[201],"ZNF318":[203],"(n=1).":[204],"Median":[205],"follow-up":[206],"was":[210,224,442,455],"37.9":[211],"(IQR:":[213,227,236],"23.9-Not":[214],"reached).":[215],"The":[216],"median":[217],"age":[218],"time":[220,414],"draw":[223],"55":[225],"years":[226,235],"8.5)":[228],"vs.":[233,322,351],"51":[234],"16.5)":[237],"without":[240,251,267,288,315,327,345],"CHIP.":[241,316,433],"Ten":[242],"(45%)":[243],"47":[248],"(37%)":[249],"current":[254],"or":[255,277,314,362],"former":[256],"smokers.":[257],"Two":[258],"(9%)":[259],"10":[264],"(7.9%)":[265],"carriers":[273],"BRCA1,":[275],"BRCA2":[276],"PALB2.":[278],"Twenty-two":[279],"(100%)":[280],"124":[285],"(98%)":[286],"had":[290,329,340,373],"received":[291,310,330],"systemic":[292],"prior":[296,333],"draw.":[299,336],"There":[300],"significant":[303],"differences":[304],"regimen":[309],"patients":[312,438],"Twenty":[317],"(90.9%)":[318],"96":[323],"(75.6%)":[324],"radiation":[331],"therapy":[332],"Pts":[337,370],"similar":[341,387],"OS":[342,348],"those":[344],"(median":[347],"7.75":[349],"[2.20-31.7]":[350],"9.33":[352],"[8.02-11.73]":[353],"months).":[354],"No":[355],"developed":[357],"therapy-related":[358],"myeloid":[359],"neoplasms":[360],"(t-MN)":[361],"died":[363],"complications":[365],"cardiac":[367],"disease.":[368],"Conclusions.":[369],"higher":[375],"frequency":[376],"than":[379],"previously":[380],"reported":[381],"age-matched":[383],"healthy":[384],"populations,":[385],"but":[386,421],"prevalence":[389],"what":[391],"has":[392],"been":[393],"seen":[394],"cohorts":[396],"solid":[400],"tumors.":[401],"Our":[402],"only":[411],"point":[415],"early":[416],"course,":[420],"sampling":[424],"later":[425],"might":[428],"reveal":[429],"additional":[430],"cases":[431],"Though":[434],"life-limiting":[440],"small,":[443],"first":[449],"diagnosis":[454],"not":[456],"associated":[457],"worse":[459],"survival.":[460],"Citation":[461],"Format:":[462],"Katheryn":[463],"Santos,":[464],"Qingchun":[465],"Jin,":[466],"Peter":[467],"G.":[468,487],"Miller,":[469],"Ashka":[470],"Patel,":[471],"Gregory":[472],"J.":[473,490],"Kirkner,":[474],"Janet":[475],"L.":[476],"Files,":[477],"Melissa":[478],"E.":[479,499],"Hughes,":[480],"Samantha":[481],"M.":[482],"Stokes,":[483],"Nabihah":[484],"Tayob,":[485],"Daniel":[486],"Stover,":[488],"Christopher":[489],"Gibson,":[491],"Eric":[492],"P.":[493],"Winer,":[494],"Nancy":[495],"U.":[496],"Lin,":[497],"Judy":[498],"Garber,":[500],"Heather":[501],"A.":[502],"Parsons.":[503],"[abstract].":[516],"In:":[517],"Proceedings":[518],"2021":[521,527],"San":[522,530],"Antonio":[523],"Breast":[524],"Cancer":[525,536],"Symposium;":[526],"Dec":[528],"7-10;":[529],"Antonio,":[531],"TX.":[532],"Philadelphia":[533],"(PA):":[534],"AACR;":[535],"Res":[537],"2022;82(4":[538],"Suppl):Abstract":[539],"nr":[540],"P3-08-01.":[541]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-04-03T00:00:00"}